← Back to Search

#HerHeart tool for Cardiovascular Disease

Waitlist Available
Led By Holly Gooding, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 13-21 years
Self-identifying as female
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 month post-enrollment
Awards & highlights

Study Summary

This trial will test how well a web tool called #HerHeart works in helping adolescent and young adult women and their healthcare providers communicate about heart health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 month post-enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 month post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
#HerHEART Risk Score in AYA From Baseline
Alcohol Consumption
Cereal Fiber
+7 more
Secondary outcome measures
BMI From Baseline
Diastolic Blood Pressure (BP) From Baseline
Systolic Blood Pressure (BP) From Baseline

Trial Design

1Treatment groups
Experimental Treatment
Group I: AYA participantsExperimental Treatment1 Intervention
AYA participants will complete a brief initial survey consisting of demographic information and the Visual Analog Scale (VAS) and the #HerHeart tool in clinic. AYA participants will the rate the usability of the #HerHeart tool using the Website Analysis and Measurement Inventory (WAMMI), the likelihood they would recommend the app to their friends, and the likelihood of behavior change. AYA participants will then be offered the opportunity to continue into the 3-month intervention phase.
First Studied
Drug Approval Stage
How many patients have taken this drug
#HerHeart tool

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,827 Previous Clinical Trials
47,300,767 Total Patients Enrolled
Emory UniversityLead Sponsor
1,635 Previous Clinical Trials
2,560,071 Total Patients Enrolled
Holly Gooding, MDPrincipal InvestigatorEmory University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current population size of participants for this clinical investigation?

"Affirmative. The clinicaltrial.gov portal confirms that this trial is still recruiting, which began on July 1st 2022 and was recently edited on November 10th 2022. 60 participants are needed across two medical centres to complete the study."

Answered by AI

Are enrollment efforts for this trial ongoing at present?

"According to clinicaltrials.gov, this ongoing study is searching for participants with recruitment beginning on July 1st 2022 and the most recent update being November 10th 2022."

Answered by AI
~22 spots leftby Apr 2025